Cancer is a leading cause of death in canines, with 1 in 4 dogs in the u.s Expected to be diagnosed with cancer in their lifetime.² 73% of pet owners are interested in having a cancer screening test for their pet—and now you can offer them one.³ the revolutionary technology behind idexx cancer dx testing detects a proprietary, circulating biomarker. Idexx laboratories shared earlier this month the launch of idexx cancer dx, a diagnostic panel with early detection of lymphoma in canine patients The new panel is an accessible blood test that can be added to the panels of sick pets and can be integrated into annual wellness screenings. Multidimensional interrogation of cells in their natural state combined with multiple wavelengths of light and. Idexx cancer dx with canine lymphoma will be available at the idexx reference laboratories in the u.s
And canada in late march 2025 For more information, visit the idexx cancer dx testing web page. What is idexx cancer dx testing Idexx cancer dxtm testing is a groundbreaking diagnostic using multiple innovative, proprietary technologies to accurately detect circulating biomarkers specific for canine lymphoma In many cases, a lymphoma phenotype is provided with high confidence, guiding prognosis and treatment plans.
OPEN
